No abstract available
Keywords:
NTRK fusion; Osimertinib resistance; Targeted therapy.
MeSH terms
-
Acrylamides / pharmacology*
-
Acrylamides / therapeutic use*
-
Adenocarcinoma of Lung / drug therapy*
-
Aged
-
Aniline Compounds / pharmacology*
-
Aniline Compounds / therapeutic use*
-
Female
-
Humans
-
Receptor, Notch2 / drug effects*
-
Receptor, trkA / drug effects*
Substances
-
Acrylamides
-
Aniline Compounds
-
NOTCH2 protein, human
-
NTRK1 protein, human
-
Receptor, Notch2
-
osimertinib
-
Receptor, trkA